Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS · Delayed Price · Currency is USD
0.0007
-0.0001 (-12.50%)
At close: May 5, 2026
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $380.6 thousand as of May 5, 2026. Its market cap has decreased by -22.22% in one year.
Market Cap
380.60K
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 380.60K, a decrease of -99.66%. That is a compound annual growth rate of -28.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 434.97K | -69.23% |
| Dec 31, 2025 | 1.41M | 420.00% |
| Dec 31, 2024 | 271.86K | -99.60% |
| Dec 29, 2023 | 67.15M | -83.68% |
| Dec 30, 2022 | 411.38M | -71.18% |
| Dec 31, 2021 | 1.43B | -18.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emmaus Life Sciences | 589.44K |
| Bio-Path Holdings | 584.59K |
| Regenerative Medical Technology Group | 512.42K |
| EV Biologics | 511.27K |
| Altamira Therapeutics | 457.24K |
| Actavia Life Sciences | 385.91K |
| Helix BioMedix | 382.01K |
| CNBX Pharmaceuticals | 368.94K |